جراحة القلب والصدر والأوعية الدموية (طب الاطفال)
معالجة وتحسين وقف النزف
مضادات انحلال الفبرين
Avoiding transfusions in children undergoing cardiac surgery: a meta-analysis of randomized trials of aprotinin. (يفتح نافذة جديدة)
Source: Anesth Analg 2006;102(3):731-7.
مفهرسة: PubMed 16492820
DOI: 10.1213/01.ane.0000194954.64293.61
https://www.ncbi.nlm.nih.gov/pubmed/16492820 (يفتح نافذة جديدة)
A systematic review of the use of antifibrinolytic agents in pediatric surgery and implications for craniofacial use. (يفتح نافذة جديدة)
Source: Pediatr Surg Int 2012;28(11):1059-69.
مفهرسة: PubMed 22940882
DOI: 10.1007/s00383-012-3167-6
https://www.ncbi.nlm.nih.gov/pubmed/22940882 (يفتح نافذة جديدة)
Aprotinin, transfusions, and kidney injury in neonates and infants undergoing cardiac surgery. (يفتح نافذة جديدة)
Source: Br J Anaesth 2012;108(5):830-7.
مفهرسة: PubMed 22362670
DOI: 10.1093/bja/aes002
https://www.ncbi.nlm.nih.gov/pubmed/22362670 (يفتح نافذة جديدة)
Comparison of epsilon aminocaproic acid and tranexamic acid in pediatric cardiac surgery. (يفتح نافذة جديدة)
Source: J Cardiothorac Vasc Anesth 2004;18(2):141-3.
مفهرسة: PubMed 15073700
https://www.ncbi.nlm.nih.gov/pubmed/15073700 (يفتح نافذة جديدة)
Efficacy of aprotinin, epsilon aminocaproic acid, or combination in cyanotic heart disease. (يفتح نافذة جديدة)
Source: Ann Thorac Surg 2000;70(4):1308-12.
مفهرسة: PubMed 11081890
https://www.ncbi.nlm.nih.gov/pubmed/11081890 (يفتح نافذة جديدة)
The Bayer 022 compassionate-use pediatric study. (يفتح نافذة جديدة)
Source: Ann Thorac Surg 1998;65(6 Suppl):S31-3.
مفهرسة: PubMed 9647135
https://www.ncbi.nlm.nih.gov/pubmed/9647135 (يفتح نافذة جديدة)
Differential effects of aprotinin and tranexamic acid on outcomes and cytokine profiles in neonates undergoing cardiac surgery. (يفتح نافذة جديدة)
Source: J Thorac Cardiovasc Surg 2012;143(5):1069-76.
مفهرسة: PubMed 22075061
DOI: 10.1016/j.jtcvs.2011.08.051
https://www.ncbi.nlm.nih.gov/pubmed/22075061 (يفتح نافذة جديدة)
Minimizing perioperative blood loss and transfusions in children. [Réduire les pertes sanguines et les besoins transfusionnels en chirurgie pédiatrique.] [English, French abstract] (يفتح نافذة جديدة)
Source: Can J Anaesth 2006;53(6 Suppl):S59-67.
مفهرسة: PubMed 16766791
https://www.ncbi.nlm.nih.gov/pubmed/16766791 (يفتح نافذة جديدة)
Intraoperative tranexamic acid in pediatric bloodless cardiac surgery. (يفتح نافذة جديدة)
Source: Asian Cardiovasc Thorac Ann 2014;22(9):1039-45.
مفهرسة: PubMed 24637029
DOI: 10.1177/0218492314527991
https://www.ncbi.nlm.nih.gov/pubmed/24637029 (يفتح نافذة جديدة)
The safety and efficacy of antifibrinolytic therapy in neonatal cardiac surgery. (يفتح نافذة جديدة)
Source: PLoS One 2015;10(5):e0126514.
مفهرسة: PubMed 25954976
DOI: 10.1371/journal.pone.0126514
https://www.ncbi.nlm.nih.gov/pubmed/25954976 (يفتح نافذة جديدة)
Epsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trials. (يفتح نافذة جديدة)
Source: Int J Clin Exp Pathol 2015;8(7):7978-87.
مفهرسة: PubMed 26339364
https://www.ncbi.nlm.nih.gov/pubmed/26339364 (يفتح نافذة جديدة)
Tranexamic acid versus ɛ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery. (يفتح نافذة جديدة)
Source: Eur J Cardiothorac Surg 2011;39(6):892-7.
مفهرسة: PubMed 21115357
DOI: 10.1016/j.ejcts.2010.09.041
https://www.ncbi.nlm.nih.gov/pubmed/21115357 (يفتح نافذة جديدة)
Replacement of aprotinin by ε-aminocaproic acid in infants undergoing cardiac surgery: consequences for blood loss and outcome. (يفتح نافذة جديدة)
Source: Br J Anaesth 2013;110(4):615-21.
مفهرسة: PubMed 23213034
DOI: 10.1093/bja/aes430
https://www.ncbi.nlm.nih.gov/pubmed/23213034 (يفتح نافذة جديدة)
Hematologic and economic impact of aprotinin in reoperative pediatric cardiac operations. (يفتح نافذة جديدة)
Source: Ann Thorac Surg 1998;66(2):535-40; discussion 541.
مفهرسة: PubMed 9725399
https://www.ncbi.nlm.nih.gov/pubmed/9725399 (يفتح نافذة جديدة)
Efficacy of tranexamic acid as compared to aprotinin in open heart surgery in children. (يفتح نافذة جديدة)
Source: Ann Card Anaesth 2015;18(1):23-6.
مفهرسة: PubMed 25566706
DOI: 10.4103/0971-9784.148316
https://www.ncbi.nlm.nih.gov/pubmed/25566706 (يفتح نافذة جديدة)
Comparative analysis of antifibrinolytic medications in pediatric heart surgery. (يفتح نافذة جديدة)
Source: J Thorac Cardiovasc Surg 2012;143(3):550-7.
مفهرسة: PubMed 22264414
DOI: 10.1016/j.jtcvs.2011.06.048
https://www.ncbi.nlm.nih.gov/pubmed/22264414 (يفتح نافذة جديدة)
The efficacy of tranexamic acid versus placebo in decreasing blood loss in pediatric patients undergoing repeat cardiac surgery. (يفتح نافذة جديدة)
Source: Anesth Analg 1997;84(5):990-6.
مفهرسة: PubMed 9141920
https://www.ncbi.nlm.nih.gov/pubmed/9141920 (يفتح نافذة جديدة)
Effective tranexamic acid concentration for 95% inhibition of tissue-type plasminogen activator induced hyperfibrinolysis in children with congenital heart disease: A prospective, controlled, in-vitro study. (يفتح نافذة جديدة)
Source: Eur J Anaesthesiol 2015;32(12):844-50.
مفهرسة: PubMed 26258658
DOI: 10.1097/EJA.0000000000000316
https://www.ncbi.nlm.nih.gov/pubmed/26258658 (يفتح نافذة جديدة)
Comparison of different doses of ε-aminocaproic acid in children for tetralogy of Fallot surgery: clinical efficacy and safety. (يفتح نافذة جديدة)
Source: J Cardiothorac Vasc Anesth 2013;27(1):23-9.
مفهرسة: PubMed 22995453
DOI: 10.1053/j.jvca.2012.07.001
https://www.ncbi.nlm.nih.gov/pubmed/22995453 (يفتح نافذة جديدة)
Comparison of three dose regimens of aprotinin in infants undergoing the arterial switch operation. (يفتح نافذة جديدة)
Source: Ann Card Anaesth 2010;13(2):110-5.
مفهرسة: PubMed 20442540
DOI: 10.4103/0971-9784.62935
https://www.ncbi.nlm.nih.gov/pubmed/20442540 (يفتح نافذة جديدة)
Pharmacokinetics of tranexamic acid in neonates, infants, and children undergoing cardiac surgery with cardiopulmonary bypass. (يفتح نافذة جديدة)
Source: Anesthesiology 2015;122(4):746-58.
مفهرسة: PubMed 25585004
DOI: 10.1097/ALN.0000000000000570
https://www.ncbi.nlm.nih.gov/pubmed/25585004 (يفتح نافذة جديدة)
Efficacy and safety of aprotinin in neonatal congenital heart operations. (يفتح نافذة جديدة)
Source: Ann Thorac Surg 2011;92(3):958-63.
مفهرسة: PubMed 21871283
DOI: 10.1016/j.athoracsur.2011.04.094
https://www.ncbi.nlm.nih.gov/pubmed/21871283 (يفتح نافذة جديدة)
The effect of preoperative tranexamic acid on blood loss after cardiac operations in children. (يفتح نافذة جديدة)
Source: J Thorac Cardiovasc Surg 1996;111(5):982-7.
مفهرسة: PubMed 8622323
https://www.ncbi.nlm.nih.gov/pubmed/8622323 (يفتح نافذة جديدة)
العامل السابع المفعَّل المأشوب أ (rFVIIa)
Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery. (يفتح نافذة جديدة)
Source: Ann Thorac Surg 2007;84(1):161-8.
مفهرسة: PubMed 17588404
DOI: 10.1016/j.athoracsur.2007.02.051
https://www.ncbi.nlm.nih.gov/pubmed/17588404 (يفتح نافذة جديدة)
Pediatric off-label use of recombinant factor VIIa. (يفتح نافذة جديدة)
Source: Pediatrics 2009;123(3):1066-72.
مفهرسة: PubMed 19255041
DOI: 10.1542/peds.2008-1685
https://www.ncbi.nlm.nih.gov/pubmed/19255041 (يفتح نافذة جديدة)
Factor VII for excessive bleeding following congenital heart disease surgery. (يفتح نافذة جديدة)
Source: Asian Cardiovasc Thorac Ann 2012;20(2):120-5.
مفهرسة: PubMed 22499956
DOI: 10.1177/0218492311433614
https://www.ncbi.nlm.nih.gov/pubmed/22499956 (يفتح نافذة جديدة)
Use of recombinant factor VIIa for uncontrolled bleeding in neonates after cardiopulmonary bypass. (يفتح نافذة جديدة)
Source: Paediatr Anaesth 2009;19(4):364-70.
مفهرسة: PubMed 19143947
DOI: 10.1111/j.1460-9592.2008.02905.x
https://www.ncbi.nlm.nih.gov/pubmed/19143947 (يفتح نافذة جديدة)
Review of the off-label use of recombinant activated factor VII in pediatric cardiac surgery patients. (يفتح نافذة جديدة)
Source: Anesth Analg 2012;115(2):364-78.
مفهرسة: PubMed 22652310
DOI: 10.1213/ANE.0b013e31825aff10
https://www.ncbi.nlm.nih.gov/pubmed/22652310 (يفتح نافذة جديدة)
Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery? (يفتح نافذة جديدة)
Source: Interact Cardiovasc Thorac Surg 2012;15(4):690-4.
مفهرسة: PubMed 22811512
DOI: 10.1093/icvts/ivs309
https://www.ncbi.nlm.nih.gov/pubmed/22811512 (يفتح نافذة جديدة)
Cardiac surgery without blood products in a Jehovah's Witness child with factor VII deficiency. (يفتح نافذة جديدة)
Source: J Cardiothorac Vasc Anesth 2012;26(4):651-3.
مفهرسة: PubMed 21924639
DOI: 10.1053/j.jvca.2011.07.012
https://www.ncbi.nlm.nih.gov/pubmed/21924639 (يفتح نافذة جديدة)
Use of recombinant activated factor VII for controlling refractory postoperative bleeding in children undergoing cardiac surgery with cardiopulmonary bypass. (يفتح نافذة جديدة)
Source: J Cardiothorac Vasc Anesth 2011;25(6):987-94.
مفهرسة: PubMed 21835642
DOI: 10.1053/j.jvca.2011.05.012
https://www.ncbi.nlm.nih.gov/pubmed/21835642 (يفتح نافذة جديدة)
Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery. (يفتح نافذة جديدة)
Source: J Clin Anesth 2014;26(3):204-11.
مفهرسة: PubMed 24809789
DOI: 10.1016/j.jclinane.2013.10.015
https://www.ncbi.nlm.nih.gov/pubmed/24809789 (يفتح نافذة جديدة)
Recombinant activated factor VII for hemorrhage after pediatric cardiac surgery. (يفتح نافذة جديدة)
Source: Asian Cardiovasc Thorac Ann 2012;20(1):19-23.
مفهرسة: PubMed 22371937
DOI: 10.1177/0218492311432584
https://www.ncbi.nlm.nih.gov/pubmed/22371937 (يفتح نافذة جديدة)
Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant. (يفتح نافذة جديدة)
Source: Pediatr Crit Care Med 2003;4(1):49-51.
مفهرسة: PubMed 12656542
DOI: 10.1097/01.PCC.0000031472.55687.4E
https://www.ncbi.nlm.nih.gov/pubmed/12656542 (يفتح نافذة جديدة)
Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients. (يفتح نافذة جديدة)
Source: J Intensive Care Med 2004;19(5):270-3.
مفهرسة: PubMed 15358945
DOI: 10.1177/0885066604267783
https://www.ncbi.nlm.nih.gov/pubmed/15358945 (يفتح نافذة جديدة)
Recombinant activated factor VII in cardiac surgery: a systematic review. (يفتح نافذة جديدة)
Source: Ann Thorac Surg 2007;83(2):707-14.
مفهرسة: PubMed 17258029
DOI: 10.1016/j.athoracsur.2006.10.033
https://www.ncbi.nlm.nih.gov/pubmed/17258029 (يفتح نافذة جديدة)
Defining the role of recombinant activated factor VII in pediatric cardiac surgery: where should we go from here? (يفتح نافذة جديدة)
Source: Pediatr Crit Care Med 2009;10(5):572-82.
مفهرسة: PubMed 19451849
DOI: 10.1097/PCC.0b013e3181a642d5
https://www.ncbi.nlm.nih.gov/pubmed/19451849 (يفتح نافذة جديدة)
Decreasing the need for transfusion: infant cardiac surgery using hemodilution and recombinant factor VIIa. (يفتح نافذة جديدة)
Source: Pediatr Cardiol 2013;34(1):119-24.
مفهرسة: PubMed 22760694
DOI: 10.1007/s00246-012-0398-1
https://www.ncbi.nlm.nih.gov/pubmed/22760694 (يفتح نافذة جديدة)
Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. (يفتح نافذة جديدة)
Source: Pediatr Hematol Oncol 2008;25(4):301-11.
مفهرسة: PubMed 18484474
DOI: 10.1080/08880010802016904
https://www.ncbi.nlm.nih.gov/pubmed/18484474 (يفتح نافذة جديدة)
مركزات عامل التخثُّر
Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (يفتح نافذة جديدة)
Source: Artif Organs 2010;34(11):955-60.
مفهرسة: PubMed 21092037
DOI: 10.1111/j.1525-1594.2010.01148.x
https://www.ncbi.nlm.nih.gov/pubmed/21092037 (يفتح نافذة جديدة)
Plasma fibrinogen concentration is correlated with postoperative blood loss in children undergoing cardiac surgery. A retrospective review. (يفتح نافذة جديدة)
Source: Eur J Anaesthesiol 2014;31(6):317-26.
مفهرسة: PubMed 24503704
DOI: 10.1097/EJA.0000000000000043
https://www.ncbi.nlm.nih.gov/pubmed/24503704 (يفتح نافذة جديدة)
Efficacy and safety of fibrinogen concentrate in surgical patients: a meta-analysis of randomized controlled trials. (يفتح نافذة جديدة)
Source: J Cardiothorac Vasc Anesth 2016;30(5):1196-204.
مفهرسة: PubMed 27493092
DOI: 10.1053/j.jvca.2016.04.015
https://www.ncbi.nlm.nih.gov/pubmed/27493092 (يفتح نافذة جديدة)
Hemostatic effects of fibrinogen concentrate compared with cryoprecipitate in children after cardiac surgery: a randomized pilot trial. (يفتح نافذة جديدة)
Source: J Thorac Cardiovasc Surg 2014;148(4):1647-55.
مفهرسة: PubMed 24951020
DOI: 10.1016/j.jtcvs.2014.04.029
https://www.ncbi.nlm.nih.gov/pubmed/24951020 (يفتح نافذة جديدة)
Four-factor prothrombin complex concentrates in paediatric patients—a retrospective case series. (يفتح نافذة جديدة)
Source: Vox Sang 2016;110(3):253-7.
مفهرسة: PubMed 26509839
DOI: 10.1111/vox.12353
https://www.ncbi.nlm.nih.gov/pubmed/26509839 (يفتح نافذة جديدة)
ديزموبريسين
Minimizing perioperative blood loss and transfusions in children. [Réduire les pertes sanguines et les besoins transfusionnels en chirurgie pédiatrique.] [English, French abstract] (يفتح نافذة جديدة)
Source: Can J Anaesth 2006;53(6 Suppl):S59-67.
مفهرسة: PubMed 16766791
https://www.ncbi.nlm.nih.gov/pubmed/16766791 (يفتح نافذة جديدة)
Anesthetic management in a pediatric patient with Noonan syndrome, mastocytosis, and von Willebrand disease: a case report. (يفتح نافذة جديدة)
Source: AANA J 2007;75(4):261-4.
مفهرسة: PubMed 17711156
https://www.ncbi.nlm.nih.gov/pubmed/17711156 (يفتح نافذة جديدة)
العلاجات الموضعية لوقف النزيف
A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. (يفتح نافذة جديدة)
Source: Ann Surg 2010;251(2):217-28.
مفهرسة: PubMed 20010084
DOI: 10.1097/SLA.0b013e3181c3bcca
https://www.ncbi.nlm.nih.gov/pubmed/20010084 (يفتح نافذة جديدة)
Resternotomy in pediatric cardiac surgery: CoSeal initial experience. (يفتح نافذة جديدة)
Source: Interact Cardiovasc Thorac Surg 2007;6(1):21-3.
مفهرسة: PubMed 17669759
DOI: 10.1510/icvts.2006.141531
https://www.ncbi.nlm.nih.gov/pubmed/17669759 (يفتح نافذة جديدة)
اختبارات اللزوجة المرنة لتحديد النزيف الجراحي أو التخثري (تجلط الدم)
Utility of Sonoclot analysis and tranexamic acid in tetralogy of Fallot patients undergoing intracardiac repair. (يفتح نافذة جديدة)
Source: Ann Card Anaesth 2012;15(1):26-31.
مفهرسة: PubMed 22234018
DOI: 10.4103/0971-9784.91477
https://www.ncbi.nlm.nih.gov/pubmed/22234018 (يفتح نافذة جديدة)
Perioperative monitoring of thromboelastograph on blood protection and recovery for severely cyanotic patients undergoing complex cardiac surgery. (يفتح نافذة جديدة)
Source: Artif Organs 2010;34(11):955-60.
مفهرسة: PubMed 21092037
DOI: 10.1111/j.1525-1594.2010.01148.x
https://www.ncbi.nlm.nih.gov/pubmed/21092037 (يفتح نافذة جديدة)
Thromboelastometry-guided intraoperative haemostatic management reduces bleeding and red cell transfusion after paediatric cardiac surgery. (يفتح نافذة جديدة)
Source: Br J Anaesth 2015;114(1):91-102.
مفهرسة: PubMed 25303988
DOI: 10.1093/bja/aeu339
https://www.ncbi.nlm.nih.gov/pubmed/25303988 (يفتح نافذة جديدة)